Walpole et al., “Analogues of Capsaicin with Agonist Activity as Novel Analgesic Agents; Structure-Activity Studies. 1. The Aromatic ‘A-Region’,” J. Med. Chem. vol. 36, pp. 2362-2372 (1993). |
English abstract of Masatoshi et al., JP7215952 A 19950815, with attached first page of JP 7-215952. |
Pertovaara et al., “Pain Behavior and Response Properties of Spinal Dorsal Horn Neurons Following Experimental Diabetic Neuropathy in the Rat: Modulation by Nitecapone, a COMT Inhibitor with Antioxidant Properties,” Experimental Neurology, vol. 167, pp. 425-434 (2001). |
S. H. Ferreira et al., “Bradykinin Initiates Cytokine-Mediated Inflammatory Hyperalgesia”, Br. J. Pharmacol., vol. 110, pp. 1227-1231 (1993). |
F. Q. Cunha et al., “Pharmacological Modulation Of Secondary Mediator Systems—Cyclic AMP And Cyclic GMP—On Inflammatory Hyperalgesia”, British Journal of Pharmacology, vol. 127, pp. 671-678 (1999). |
P. A. Aho et al., “Role Of Gastric Mucosal Eicosanoid Production In The Cytoprotection Induced By Nitecapone”, Scand. J. Gastroenterol, vol. 27, pp. 134-138 (1992). |
C. J. Sih et al., “Mechanism of Prostaglandin Biosynthesis”, Journal of the American Chemical Society, vol. 92, p. 6670 (1970). |
D. W. Busija et al., “Eicosanoid Synthesis Elicited By Norepinephrine In Piglet Parietal Cortex”, Brain Research, vol. 403, pp. 243-248 (1987). |
L. O. Randall et al., “A Method For Measurement Of Analgesic Activity On Inflamed Tissue”, Arch. Int. Pharmacodyn., vol. 111, pp. 409-419 (1957). |
K. Gyires et al., “The Use Of The Writhing Test In Mice For Screening Different Types Of Analgesics”, Arch. Int. Pharmacodyn., vol. 267, pp. 131-140 (1984). |
N. B. Eddy et al., “Synthetic Analgesics”, J. Pharmacol. Ther., vol. 98, pp. 121-137 (1950). |
E. Rivas et al., “In Vivo Effects Of New Inhibitors Of Catechol-O-Methyl Transferase”. British Journal of Pharmacology, vol. 126, pp. 1667-1673 (1999). |
R. A. Pérez et al., “Dihydroxynitrobenzaldehydes And Hydroxymethoxynitrobenzaldehydes: Synthesis And Biological Activity as Catechol-O-Methyltransferase Inhibitors”, J. Med. Chem., vol. 35, pp. 4584-4588 (1992). |
R. A. Pérez et al., “Inhibition Of Catechol-O-Methyltransferase By 1-Vinyl Derivatives Of Nitrocatechols And Nitroguaiacols”, Biochemical Pharmacology, vol. 45, No. 10, pp. 1973-1981 (1993). |
A. C. Eclöf et al., “Natriuretic And Vasodilating Effects of Dopamine Are Mimicked By Oral Administration of a Catechol-O-Methyltransferase (COMP) Inhibitor”, J. Am. Soc. Nephrology, vol. 5, paragraph 23P, p. 657 (1994). |
U. Holtbäck et al., “Regulators of Renal Dopamine Metabolism Control Salt Excretion”, .J. Am. Soc. Nephrology, vol. 7, Paragraph A1922, p. 1633 (1996). |
K. L. Green, “The Anti-Inflammatory Effect of Catecholamines In The Peritoneal Cavity And Hind Paw Of The Mouse”, Br. J. Pharmac., vol. 45, pp. 322-332 (1972). |
S. K. Bhattacharya et al., “Central Catecholaminergic Modulation Of Carrageenin-Induced Pedal Oedema in Rats”, Res Exp Med, vol. 186, pp. 365-374 (1986). |
M. Nakamura et al., “A Peripheral Sympathetic Component In Inflammatory Hyperalgesia”, European Journal of Pharmacology, vol. 135, pp. 145-153 (1987). |